About Lykos
Lykos is a Government & Social Sector company based in San Jose (United States) founded in 2014. It operates as a developer of therapeutics to treat mental health conditions. It operates in the Government & Social Sector and Healthcare sectors. Lykos has raised $315.1 million across 2 funding rounds from investors including Helena, Steveandalex and Vine Ventures. Its chief executive is Amy Emerson. Lykos offers products and services including Midomafetamine Capsules. Its focus areas include Healthcare Foundations and Traditional Pharmaceuticals. Its competitors include GH Research, Small Pharma and Ketabon; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2014 and based in San Jose, United States, Lykos operates in the biotechnology sector focused on mental health treatments. Therapeutics are developed to address conditions such as post-traumatic stress disorder through a combination of MDMA capsules, psychological interventions, and supportive services. Operations emphasize clinical development and integration of pharmacological and therapeutic approaches for patient care.
- Headquarters San Jose, United States
- SectorsGovernment & Social SectorHealthcare
- Website category Health · Addictions
- Email••••••••
- Phone•••• ••••
- Website lykospbc.com
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$315.1M (USD)
in 2 rounds
- Latest Funding Round$100M (USD), Series A
Jan 2024
- InvestorsHelena
& 7 more
Products & Services of Lykos
Lykos offers a comprehensive portfolio of products and services, including Midomafetamine Capsules.
Investigational treatment for PTSD using psychedelic compounds
Funding Insights of Lykos
Lykos has successfully raised a total of $315.1M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $100 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $315.1M
- Total Rounds 2
- Last Round Series A — $100M
- First Round $215.1M
(Sep 2023)
- Investors Count 8
All 2 funding rounds of Lykos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $100M | Series A | – | Helena | |
| Sep 2023 | $215.1M | Series A | – | – | – |
8 investors in total: 8 institutional.
Investors in Lykos
Lykos has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Helena, Steveandalex and Vine Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are directed toward early-stage technology companies. | – | vineventures.com | New York, United States | |
Venture capital firm supporting AI founders through investments and community. | – | trueventures.com | - | |
- | – | kittyhawk.vc | - | |
Investment firm specializing in private equity, alternatives, and thematic strategies with a focus on long-term value. | – | satoricapital.com | - | |
Global issues of importance are addressed via magazine publications. | 2015 | helena.org | Los Angeles, United States | |
- | – | steveandalex.org | - | |
Support is provided to leaders and communities for unique collaborations. | – | unlikely.foundation | - | |
Grants are provided by the foundation to support underserved communities. | 2008 | jssf.org | New York, United States |
Investor details for Lykos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lykos
1 people are tracked at Lykos (1 in leadership).
| Name | Role | Group |
|---|---|---|
Amy Emerson | CEO | Leadership |
Complete people profiles for Lykos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lykos
3 dated milestones of Lykos across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Lykos is founded.
- Funding First funding round of $215.1M.
- Funding Latest funding round, Series A, of $100.0M.
Competitors of Lykos
Lykos has 3 listed competitors in our database, 2 of them funded. They include GH Research, Small Pharma and Ketabon, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ghres.com | 2018 | Dublin, Ireland | $125M | – | Therapeutics for mental disease management are developed using 5-MeO-DMT formulations. | |
| smallpharma.com | 2015 | London, United Kingdom | $49.17M | 9 | Psychedelic-based therapeutics for mental health conditions are developed. | |
| ketabon.health | 2022 | Munich, Germany | – | – | Develops innovative therapeutics for treatment-resistant depression. |
Detailed competitors of Lykos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lykos
The website of Lykos (lykospbc.com) receives about 9K visits a month and ranks #3,114,580 among all websites worldwide, #3,234 in Addictions.
- Monthly visits9K
▲ 49.1% vs previous month
- Unique visitors2.9K
per month
- Global rank#3,114,580
among all websites
- Category rank#3,234
Health · Addictions
- Bounce rate33%
- Pages per visit2.0
- Average visit3 min 30 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with Lykos. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| soundmind.center | 100% | 2.3K | #7,827,295 | View details | |
| fluencetraining.com | 99% | 12.4K | #1,597,685 | View details | |
psychedelicalpha.com | psychedelicalpha.com | 84% | – | #671,527 | – |
Top companies in Healthcare Foundations
10 companies that operate in the same segment as Lykos (Healthcare Foundations), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Social injustice is combated through modern medical science benefits. | 1987 | United States | USD 25 M | – | – | |
Provider of mouse models, services, and educational resources for biomedical research | 1929 | United States | – | – | – | |
Disease control and prevention services are provided nationwide. | 1946 | United States | – | – | – | |
Health benefit plans, programs, and services are provided nationwide. | 1969 | United States | – | – | 1,413 | |
Provider of healthcare services and a network of care | – | United States | – | – | – | |
Universal health coverage is expanded via global public health efforts. | 1945 | United States | – | – | – | |
Global health solutions are developed and delivered to enhance outcomes. | 1977 | United States | – | – | 576 | |
Kidney disease information and support services are provided. | – | – | – | – | – | |
Provider of orthopedic surgery education, research, and innovation | 1958 | Davos, Graubunden, Switzerland | – | – | – | |
Regional services in healthcare, culture, and transportation are managed. | – | Sweden | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lykos
Complete news archive for Lykos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lykos
Lykos was founded in 2014 and raised its 1st funding round 9 years after it was founded.
Lykos is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Amy Emerson is the current CEO of Lykos.
Lykos is a funded company, having raised a total of $315.1M across 2 funding rounds to date. The company's 1st funding round was a Series A of $215.1M, raised on Sep 2023.
Founded in 2014 and based in San Jose, United States, Lykos operates in the biotechnology sector focused on mental health treatments. Therapeutics are developed to address conditions such as post-traumatic stress disorder through a combination of MDMA capsules, psychological interventions, and supportive services. Operations emphasize clinical development and integration of pharmacological and therapeutic approaches for patient care.
Lykos's top competitors include GH Research, Small Pharma and Ketabon.
Lykos offers Midomafetamine Capsules.
Lykos has 8 investors. Key investors include Helena, Steveandalex, Vine Ventures, True Ventures, and Unlikely Collaborators Foundation.